9
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis

      research-article

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          SUMMARY

          Mutation of highly conserved residues in transcription factors may affect protein-protein or protein-DNA interactions leading to gene network dysregulation and human disease. Human mutations in GATA4, a cardiogenic transcription factor, cause cardiac septal defects and cardiomyopathy. Here, iPS-derived cardiomyocytes from subjects with a heterozygous GATA4-G296S missense mutation showed impaired contractility, calcium handling and metabolic activity. In human cardiomyocytes, GATA4 broadly co-occupied cardiac enhancers with TBX5, another transcription factor that causes septal defects when mutated. The GATA4-G296S mutation disrupted TBX5 recruitment, particularly to cardiac super-enhancers, concomitant with dysregulation of genes related to the phenotypic abnormalities, including cardiac septation. Conversely, the GATA4-G296S mutation led to failure of GATA4 and TBX5-mediated repression at non-cardiac genes and enhanced open chromatin states at endothelial/endocardial promoters. These results reveal how disease-causing missense mutations disrupt transcriptional cooperativity, leading to aberrant chromatin states and cellular dysfunction, including those related to morphogenetic defects.

          Graphical abstract

          A human missense mutation that causes congenital heart defects disrupts the cooperation between transcription factors at cardiac super-enhancers and gives rise to aberrant expression of endothelial genes

          Related collections

          Most cited references30

          • Record: found
          • Abstract: found
          • Article: not found

          The selection and function of cell type-specific enhancers.

          The human body contains several hundred cell types, all of which share the same genome. In metazoans, much of the regulatory code that drives cell type-specific gene expression is located in distal elements called enhancers. Although mammalian genomes contain millions of potential enhancers, only a small subset of them is active in a given cell type. Cell type-specific enhancer selection involves the binding of lineage-determining transcription factors that prime enhancers. Signal-dependent transcription factors bind to primed enhancers, which enables these broadly expressed factors to regulate gene expression in a cell type-specific manner. The expression of genes that specify cell type identity and function is associated with densely spaced clusters of active enhancers known as super-enhancers. The functions of enhancers and super-enhancers are influenced by, and affect, higher-order genomic organization.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes

            SUMMARY The reprogramming of adult cells into pluripotent cells or directly into alternative adult cell types holds great promise for regenerative medicine. We reported that cardiac fibroblasts, which represent 50% of the cells in the mammalian heart, can be directly reprogrammed to adult cardiomyocyte-like cells in vitro by the addition of Gata4, Mef2c and Tbx5 (GMT). Here, we use genetic lineage-tracing to show that resident non-myocytes in the murine heart can be reprogrammed into cardiomyocyte-like cells in vivo by local delivery of GMT after coronary ligation. Induced cardiomyocytes became bi-nucleate, assembled sarcomeres and had cardiomyocyte-like gene expression. Analysis of single cells revealed ventricular cardiomyocyte-like action potentials, beating upon electrical stimulation, and evidence of electrical coupling. In vivo delivery of GMT decreased infarct size and modestly attenuated cardiac dysfunction up to 3 months after coronary ligation. Delivery of the pro-angiogenic and fibroblast activating peptide, Thymosin β4, along with GMT, resulted in further improvements in scar area and cardiac function. These findings demonstrate that cardiac fibroblasts can be reprogrammed into cardiomyocyte-like cells in their native environment for potential regenerative purposes.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Opening of compacted chromatin by early developmental transcription factors HNF3 (FoxA) and GATA-4.

              The transcription factors HNF3 (FoxA) and GATA-4 are the earliest known to bind the albumin gene enhancer in liver precursor cells in embryos. To understand how they access sites in silent chromatin, we assembled nucleosome arrays containing albumin enhancer sequences and compacted them with linker histone. HNF3 and GATA-4, but not NF-1, C/EBP, and GAL4-AH, bound their sites in compacted chromatin and opened the local nucleosomal domain in the absence of ATP-dependent enzymes. The ability of HNF3 to open chromatin is mediated by a high affinity DNA binding site and by the C-terminal domain of the protein, which binds histones H3 and H4. Thus, factors that potentiate transcription in development are inherently capable of initiating chromatin opening events.
                Bookmark

                Author and article information

                Journal
                0413066
                2830
                Cell
                Cell
                Cell
                0092-8674
                1097-4172
                3 December 2016
                15 December 2016
                15 December 2017
                : 167
                : 7
                : 1734-1749.e22
                Affiliations
                [1 ]Gladstone Institute of Cardiovascular Disease and Roddenberry Center for Stem Cell Biology and Medicine, San Francisco, CA, USA
                [2 ]Department of Mechanical Engineering, Stanford University, Stanford, CA, USA
                [3 ]Department of Genetics and Center for Genomics and Personalized Medicine, Stanford University, Stanford, CA, USA
                [4 ]Department of Biological Statistics and Computational Biology, Cornell University, Ithaca, NY, USA
                [5 ]Department of Pediatrics, University of California San Francisco, San Francisco, CA, USA
                [6 ]Department of Biochemistry and Biophysics, University of California San Francisco, San Francisco, CA, USA
                Author notes
                [7]

                Lead Contact

                Article
                PMC5180611 PMC5180611 5180611 nihpa831507
                10.1016/j.cell.2016.11.033
                5180611
                27984724
                5bd4f4d1-6fcb-4d51-b399-c968cfc9dfdf
                History
                Categories
                Article

                gene regulation,GATA4,TBX5,heart development,cardiomyopathy,congenital heart defects,disease modeling,systems biology,epigenetics,birth defects

                Comments

                Comment on this article